Pharmaceutical Investment

A clinical services company will be investing £9M at a site in Wales.

The company who provides clinical trial material supplies packaging, labelling and distribution. The new project will enable the company to develop the company’s manufacturing capabilities improving automated bottling, blistering and serialisation. The first phase will involve purchasing and renovation of a new facility within the existing site. This will triple the clinical service capacity of the company enabling expansion into Asia and the USA.

A system integrator based in the Northwest is able to provide conveying for the new lines and end of line packaging machinery including First in First out accumulation. The accumulation will ensure the production line is as efficient as possible between cost centres by reducing micro-stops. Also, precious labels will not be damaged due to the pressureless accumulation technology that the accumulator provides.